Skip to main content

AGENDA

AGENDA

FRIDAY, MARCH 24, 2023

12:00 – 15:30h ALLIED HEALTH PROFESSIONALS PROGRAM- Cascade Ballroom
12:00 – 12:15h Welcome
12:15 – 13:00h Multiple Myeloma Adverse Events and Frailty Discussion – Beth Faiman
13:00 – 13:45h Creative Solutions to Workload Issues – A Novel Pharmacy Led Myeloma Therapy Clinic – Marina Ebied
13:45 – 14:30h COVID-19 Treatment in Patients with Lymphoproliferative Disorders – Alisha Shivji
14:30 – 15:15h Inclusion, Diversity, Equity & Accessibility (IDEA) in Oncology Patient Care – Frances Folkman
15:15h Concluding Remarks
1600-1700h Registration and CCOLD Welcome Reception- Riverview Lounge
1700-1710h CCOLD Opening Remarks – Dr. Wendy Lam and Dr. Laurie Sehn – Cascade Ballroom
MYELOMA SESSION
1710-1715h Welcome & Introductions – Chair: Dr. Wendy Lam
1715-1735h Role of MRD in Myeloma – Dr. Chris Venner
1735-1755h Management of Ultra-High Risk Myeloma – Dr. Chris Chen
1755-1815h Bispecific Antibodies for Myeloma- Dr. Darrell White
1815-1835h CART for Myeloma- Dr. Chris Venner
1835-1855h Front-line Treatment for Myeloma

Point: ASCT- Dr. Chris Chen
Counter Point: DRd – Dr. Irwin Sandhu

1855-1920h Panel Discussion – Chair: Dr. Wendy Lam, Panel: Dr. Venner, Dr. Chen, Dr. White, Dr. Sandhu
1930h CCOLD Opening Dinner – Alberta / New Brunswick  Ballroom

SATURDAY, MARCH, 25, 2023

0630-0700h Breakfast – Riverview Room
CLL SESSION
0700-0705h Welcome and Introductions – Chair: Dr. Julie StakiwCascade Ballroom
0705-0735h Treatment form Newly Diagnosed CLL – Dr. Matthew Davids
0735-0805h Treatment for Relapsed/Refractory CLL – Dr. Constantine Tam
0805-0830h The Value of MRD in Management of CLL in 2023 – Dr. Carolyn Owen
0830-0900h Richter’s Transformation in CLL – Dr. Matthew Davids
0900-1000h Panel Discussion – Chair: Dr. Julie Stakiw, Panel: Dr. Davids, Dr. Tam, Dr. Owen
YOUNG INVESTIGATORS’ POSTER SESSION
1300-1645h Reception – Young Investigators’ Poster and Oral Presentations – Riverview Room 
1645-1700h Presentation Best Poster – Dr. Anca Prica
LYMPHOMA SESSION
1700-1705h Welcome and Introductions –  Chair: Dr. Nathalie Johnson – Cascade Ballroom
1705-1730h Best of ASH – Dr. Laurie Sehn
1730-1800h The Promise of Bispecifics in B-cell NHL – Dr. Martin Hutchings
1800-1830h Waldenstroms Macroglobulinemia – Dr. Constantine Tam
1830-1900h Mantle Cell Lymphoma – Dr. Julie Vose
1900h-1925h Panel Discussion – Chair:  Dr. Nathalie Johnson, Panel: Dr. Hutchings, Dr. Sehn, Dr. Tam, Dr. Vose 
1930h Dinner – Alhambra Ballroom /Foyer

SUNDAY MARCH 26, 2023

0630-0700h Breakfast – Riverview Room
LYMPHOMA SESSION
0700-0705h Welcome and Introductions – Dr. Anca Prica – Cascade Ballroom
0705-0730h Lymphoma Classification Systems: What You Need to Know – Dr. Julie Vose
0730-0800h Relapsed Refractory DLBCL – Dr. Jeremy Abramson
0800-0840h Debate:
Bispecifics Should be 3rd Line Treatment for DLBCL –Dr. Martin Hutchings
CART Should be 3rd Line Treatment for DLBCL- Dr. Jeremy Abramson
0840-0905h Maintenance Therapy in B-cell Lymphomas: What to Keep, What to Abandon?- Dr. Diego Villa 
0905h-0955h Panel Discussion: Chair: Dr. Anca Prica, Panel: Dr. Abramson, Dr. Hutchings, Dr. Vose, Dr. Villa 
0955-1000h Closing Remarks- Dr. Laurie Sehn and Dr. Wendy Lam